Research-Action in Hematology From Hospitalization to Home

Hematologic Cancer Clinical Trial

— RAH HD  

Official title:

Psychological Follow-up in a Protected Hematology Unit as a Transitional Device Between Hospitalization and Return Home

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06053918
• Other study ID #: 18-199
• Status: Completed
• Start date: May 7, 2019
• Est. completion date: March 31, 2021

Study information

• Verified date: July 2023
• Source: University Hospital, Caen
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Objective :

To study and support the hospitalization and the return home of patients with the help of a psychological follow-up started in a hospital institution and which will continue in the patient's home, based on the concepts of transitionality and narrativity.

Material and method To do this, the subjects will benefit from psychological interviews where they will freely discuss what concerns them, whether it is illness, treatment, returning home, or any other personal subject.

They will be divided into two groups of 5 patients each, one of the groups will benefit from follow-up in an institution as contracted for several years between the Institute of Hematology and the psychologists of the UMDSP, another from the same follow-up but with the presence of the psychologist at the time of discharge extended to the patient's home after leaving the hospital for a period of 2 months.

To ensure a certain consistency in the evaluation criteria, these will be standardized in the form of questionnaires completed blindly by the patient, a caregiver and the investigator, at 3 key times of the research (entry, discharge from hospital, two months after this discharge)

Device tested:

The aim of this work is to test the benefits of a device based on transitionality, which can limit, thanks to the restoration of the symbolization process, the deleterious effects of each of the stages imposed by the disease, the care and the resumption of autonomy once the active phase of care has passed.

Narrativity is also at the heart of this transitional device. It makes it possible to evoke the present experience of the patient in connection with future projects and in the continuity of past, potentially traumatic events. It opens onto a dynamic temporal perspective where the trauma freezes.

The whole process promotes the subjective reappropriation of the experience and a psychic well-being.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: March 31, 2021
• Est. primary completion date: March 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patient hospitalized Protected Hematology Unit

• patient with haematologic cancer

• patient requesting psychological assistance or accepting proposed psychological assistance

• signed informed consent

Exclusion Criteria:

• patient refusing to participate

• patient not able to participate

Related Conditions & MeSH terms

• Hematologic Cancer
• Hematologic Neoplasms

Intervention

Other:
• additional follow-up extension at home
additional interview when leaving the sector, and the extension of follow-up of the patient at home

Locations

Country	Name	City	State
France	CAEN University Hospital	Caen

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Caen

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Clinical evaluation of the psychological state, anxiety-depressive disorders	anxiety-depressive disorders yes or no	At hospital Month 0 and at home Month 2